Publications by authors named "Stephen T Oh"

41Publications

Unraveling the Architecture of Classic Hodgkin Lymphoma One Cell at a Time.

Cancer Discov 2020 03;10(3):342-344

Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-1538DOI Listing
March 2020

Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera.

Leukemia 2019 06 11;33(6):1522-1526. Epub 2019 Jan 11.

Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0349-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759365PMC
June 2019

JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.

Cancer Cell 2018 11;34(5):741-756.e8

Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Developmental, Regenerative and Stem Cell Biology Program, Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183047
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.10.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237100PMC
November 2018

Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States.

Clin Lymphoma Myeloma Leuk 2018 09 28;18(9):590-596. Epub 2018 May 28.

Department of Medicine (Hematology and Oncology), Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183032
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.05.020DOI Listing
September 2018

Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.

Br J Haematol 2018 10 19;183(2):310-313. Epub 2017 Oct 19.

Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14958DOI Listing
October 2018

Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature.

Curr Hematol Malig Rep 2017 10;12(5):397-405

Division of Hematology, Washington University in St. Louis School of Medicine, 660 S. Euclid Ave, Campus Box 8125, St. Louis, MO, 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0401-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671353PMC
October 2017

Analysis of Signaling Networks at the Single-Cell Level Using Mass Cytometry.

Methods Mol Biol 2017 ;1636:371-392

Division of Hematology, Washington University School of Medicine, 660 S. Euclid Ave., Campus Box 8125, St. Louis, MO, 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7154-1_24DOI Listing
April 2018

Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.

Ther Adv Hematol 2017 Mar 8;8(3):107-118. Epub 2016 Dec 8.

Division of Hematology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8125, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716680333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305004PMC
March 2017

A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis.

Br J Haematol 2017 Mar 21;176(6):939-949. Epub 2017 Feb 21.

Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14501DOI Listing
March 2017

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

N Engl J Med 2016 11;375(21):2023-2036

the Department of Internal Medicine, Division of Oncology (J.S.W., L.D.W., G.L.U., A.G., M.H.T., I.P., R.R., T.A.F., K.E.S.-G., R.V., S.T.O., C.N.A., A.F.C., M.A.S., M.A.J., S.E.H., K.L., M.R.J., M.J.W., P.W., D.C.L., J.F.D., T.J.L.), and the Division of Biostatistics (J.D.B.), and the Department of Pathology and Immunology (E.J.D., B.T., Y.-S.L.), Washington University School of Medicine, and McDonnell Genome Institute, Washington University in St. Louis (A.A.P., C.A.M., C.C.F., M.O., R.S.F., R.K.W., L.D.W., T.J.L.) - both in St. Louis; the Departments of Internal Medicine (A.H., N.K., M.J.S., W.S.) and Pharmacy (R.W.K.), University of Chicago, Chicago; and the Department of Internal Medicine (T.A.G.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1605949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217532PMC
November 2016

Concurrent MPL W515L and Y591D mutations in a patient with myelofibrosis.

Blood Cells Mol Dis 2016 09 26;60:1-2. Epub 2016 May 26.

Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2016.05.010DOI Listing
September 2016

Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.

J Clin Oncol 2015 Nov 31;33(33):3953-60. Epub 2015 Aug 31.

Brady L. Stein, Northwestern Feinberg University School of Medicine, Chicago, IL; Stephen T. Oh and Camille Abboud, Washington University School of Medicine, St Louis, MO; Dmitriy Berenzon, Wake Forest University School of Medicine, Winston Salem, NC; Gabriela S. Hobbs, Massachusetts General Hospital, Boston, MA; Marina Kremyanskaya, John Mascarenhas, and Ronald Hoffman, Mount Sinai School of Medicine; Raajit K. Rampal, Memorial Sloan Kettering Cancer Center; Mark L. Heaney, Columbia University Medical Center; Ellen K. Ritchie, Cornell University School of Medicine, New York, NY; Kenneth Adler, Regional Cancer Care Associates, Morristown, NJ; Elias J. Jabbour, MD Anderson Cancer Center; Lawrence Rice, Cornell Houston Methodist Hospital, Houston, TX; Rami S. Komrokji, Moffitt Cancer Center, Tampa, FL; and Alison R. Moliterno, Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/31/JCO.2015.61
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.61.6474
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.6474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979103PMC
November 2015

Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.

J Natl Compr Canc Netw 2015 Apr;13(4):424-34

From Northwestern University Feinberg School of Medicine, Chicago, Illinois; Stanford Cancer Institute, Stanford University, Stanford, California; Duke Cancer Institute, Duke University, Durham, North Carolina; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; University of California, San Francisco, San Francisco, California; Johns Hopkins University School of Medicine, Baltimore, Maryland; Moores Cancer Center, UC San Diego, San Diego, California; University of Colorado Cancer Center, Aurora, Colorado; Fred Hutchinson Cancer Research Center, Seattle, Washington; Dana Farber Cancer Institute, Boston, Massachusetts; Memorial Sloan Kettering Cancer Center, New York; New York; Moffitt Cancer Center and Research Institute, Tampa, Florida; The Ohio State University, Columbus, Ohio; Fred & Pamela Buffett Cancer Center, Omaha, Nebraska; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Roswell Park Cancer Institute, Buffalo, New York; Washington University-Siteman Cancer Center, St Louis, Missouri; St. Jude Children's Research Hospital, Memphis, Tennessee; University of Alabama at Birmingham, Birmingham, Alabama; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; Yale University School of Medicine; New Haven, Connecticut; University of Utah, Salt Lake City, Utah; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; City of Hope Cancer Center, Los Angeles, California; The University of Texas MD Anderson Cancer Center, Houston, Texas; and Mayo Clinic Cancer Center, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0058DOI Listing
April 2015

Prognostication in MF: from CBC to cytogenetics to molecular markers.

Best Pract Res Clin Haematol 2014 Jun 18;27(2):155-64. Epub 2014 Jul 18.

Washington University School of Medicine, Division of Hematology, 660 S. Euclid Ave, Campus Box 8125, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.07.008DOI Listing
June 2014

Pathology consultation on myeloproliferative neoplasms.

Am J Clin Pathol 2012 Jul;138(1):12-9

Division of Transfusion Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPLRIOJP55JAYTDOI Listing
July 2012

JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms.

Expert Rev Hematol 2010 Jun;3(3):323-37

Division of Hematology, Stanford Cancer Center, 875 Blake Wilbur Drive, Room 2324, Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.10.28DOI Listing
June 2010

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

Blood 2010 Aug 19;116(6):988-92. Epub 2010 Apr 19.

Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford Cancer Center, 875 Blake Wilbur Dr., Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-02-270108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924231PMC
August 2010

Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory.

J Mol Diagn 2010 Jan 3;12(1):58-64. Epub 2009 Dec 3.

Department of Pathology, Stanford University Medical Center, 300 Pasteur Dr, L235, Stanford, CA 94305-5324, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/jmoldx.2010.090068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797719PMC
January 2010

Antiangiogenic therapy in myelodysplastic syndromes: is there a role?

Curr Hematol Malig Rep 2008 Jan;3(1):10-8

Division of Hematology, Stanford Cancer Center, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-008-0003-0DOI Listing
January 2008

Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.

J Virol 2004 Mar;78(5):2620-6

Department of Microbiology-Immunology, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC369251PMC
http://dx.doi.org/10.1128/jvi.78.5.2620-2626.2004DOI Listing
March 2004